National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

This is VAERS ID 906127

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 12/24/2020

VAERS ID: 906127
VAERS Form:2
Age:
Sex:Male
Location:Texas
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:0000-00-00
Entered:2020-12-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown      Purchased by: ??
Symptoms: Dyspnoea, Hypersensitivity, Rash, Swollen tongue

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': USPFIZER INC2020500854

Write-up: severe hypersensitivity; swelling of tongue; dyspnea; skin rash; This is a spontaneous report from a non-contactable consumer. A 35-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient administered vaccine and developed swelling of tongue, dyspnea, skin rash on an unspecified date. There is a report of severe hypersensitivity for his awareness. The patient was treated with dexamethasone, Benadryl, IM epinephrine in ER. Outcome of events were unknown. No follow-up attempts are possible; information about batch/lot number cannot be obtained.


Changed on 12/30/2020

VAERS ID: 906127 Before After
VAERS Form:2
Age:
Sex:Male
Location:Texas
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:0000-00-00
Entered:2020-12-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown      Purchased by: ??
Symptoms: Dyspnoea, Hypersensitivity, Rash, Swollen tongue

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': USPFIZER INC2020500854

Write-up: severe hypersensitivity; swelling of tongue; dyspnea; skin rash; This is a spontaneous report from a non-contactable consumer. A 35-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient administered vaccine and developed swelling of tongue, dyspnea, skin rash on an unspecified date. There is a report of severe hypersensitivity for his awareness. The patient was treated with dexamethasone, Benadryl, IM epinephrine in ER. Outcome of events were unknown. No follow-up attempts are possible; information about batch/lot number cannot be obtained.


Changed on 5/7/2021

VAERS ID: 906127 Before After
VAERS Form:2
Age:
Sex:Male
Location:Texas
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:0000-00-00
Entered:2020-12-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown      Purchased by: ??
Symptoms: Dyspnoea, Hypersensitivity, Rash, Swollen tongue

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': USPFIZER INC2020500854

Write-up: severe hypersensitivity; swelling of tongue; dyspnea; skin rash; This is a spontaneous report from a non-contactable consumer. A 35-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient administered vaccine and developed swelling of tongue, dyspnea, skin rash on an unspecified date. There is a report of severe hypersensitivity for his awareness. The patient was treated with dexamethasone, Benadryl, IM epinephrine in ER. Outcome of events were unknown. No follow-up attempts are possible; information about batch/lot number cannot be obtained.


Changed on 5/21/2021

VAERS ID: 906127 Before After
VAERS Form:2
Age:
Sex:Male
Location:Texas
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:0000-00-00
Entered:2020-12-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown      Purchased by: ??
Symptoms: Dyspnoea, Hypersensitivity, Rash, Swollen tongue

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': USPFIZER INC2020500854

Write-up: severe hypersensitivity; swelling of tongue; dyspnea; skin rash; This is a spontaneous report from a non-contactable consumer. A 35-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient administered vaccine and developed swelling of tongue, dyspnea, skin rash on an unspecified date. There is a report of severe hypersensitivity for his awareness. The patient was treated with dexamethasone, Benadryl, IM epinephrine in ER. Outcome of events were unknown. No follow-up attempts are possible; information about batch/lot number cannot be obtained.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=906127&WAYBACKHISTORY=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166